Bravatek Solutions, Inc. (OTC Pink: BVTK) is engaged as a cyber security company. Shares of the cyber defense company are rallying 6.45%, through early trading on Thursday, August 31, 2017. Over the past month, Bravatek Solutions, Inc. has seen average daily volume of 217.64 million shares. However, volume of 66.52 million shares or dollar volume of $219,516, has already exchanged hands on Thursday.
Shares of Bravatek Solutions, Inc. are rallying today, after the company announced it has received a $75,000 order for its Ecrypt One software by Integro Health Systems, Inc. This is the first instance of Bravatek Solutions, Inc. software entering the healthcare industry. Here is the full press release detailing of the software sales order:
Bravatek Solutions, Inc. Press Release:
AUSTIN, TX / ACCESSWIRE / August 31, 2017 / Bravatek Solutions, Inc. (OTC PINK: BVTK, “Bravatek” or the “Company”) announces that it has received an order for its Ecrypt One software for over $75,000 from Integro Health Systems, Inc. (“Integro”).
Dr. Thomas A. Cellucci, Bravatek’s Chairman & CEO, commented, “We are pleased to formalize our special business relationship with Integro Health Systems, Inc., who is currently operating a 133-bed behavioral health facility in Arizona dedicated to treating patients with substance abuse issues, such as opioid abuse, which is unfortunately all too prevalent in the US. I do not speak only as a businessman but as a First Responder for over 30 years who was a volunteer firefighter and EMT who has authored many books and articles at the White House and US Department of Homeland Security useable by First Responders.”
Dr. Cellucci continued, “It’s important to note that The Go ECO Group (OTC PINK: LIBE), which is the parent company of Integro, plans to purchase five (5) more treatment centers (of similar size) by the end of 2018, and we anticipate additional sales of our software to Integro following their purchase. We plan to also provide Enterprise Sentinel’s multi-factor authentication software bundled in future orders to Integrorepresenting at least $470,000 in potential total orders.”
Mr. Brian Conway, CEO of Integro Health Systems, Inc., stated, “We are pleased that we’re joining forces with the Bravatek team. Their technical and marketing prowess, accomplished Board/management team, coupled with their in-depth knowledge of healthcare markets, will assist us in driving our business and most importantly protect our patients’ sensitive health records.”
To learn more about the market opportunity for potential Ecrypt One cybersecurity sales in the behavioral health industry, please read: http://www.harriswilliams.com/sites/default/files/content/hcls_behavioral_health_industry_overview.pdf.
About Bravatek Solutions, Inc.
Bravatek Solutions, Inc. is a high technology security solutions portfolio provider that assists corporate entities, governments and individuals protect their organizations against both physical and cyber-attacks through its offering of the most technically-advanced, cost-effective and reliable software, tools and systems.
For more information, visit www.bravatek.com
About Integro Health Systems, Inc.
Integro offers a unique, new integrated approach for serving the growing population of patients with behavioral health crises. Integro delivers priority, comprehensive care for these patients with a proven team led by medical doctors, psychiatrists, and other specialists. Services include Urgent Care, Inpatient Care, Detoxification, and Intensive Outpatient Care.
Safe Harbor Statement
This press release contains certain “forward-looking statements”, as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.